Core Viewpoint - The report from Huayuan Securities indicates that Mao Geping (01318), a domestic high-end cosmetics brand, is experiencing steady growth in skincare and makeup categories, with significant advantages in both offline and online channels. The brand's momentum is on an upward trajectory, and the single product matrix continues to grow rapidly. The company's IP brand value, channel endowment, and future growth potential are viewed positively, leading to a high certainty of performance growth, maintaining a "Buy" rating [1]. Group 1 - The company announced a voluntary shareholder reduction plan, where the controlling shareholder and executive directors plan to reduce their holdings by up to 3.51% of the total issued shares within six months, primarily through block trading. The proceeds will be used for investments in the beauty industry and personal improvements. The controlling shareholders express confidence in the company's development and will continue to focus on product research and operational management to enhance brand value and performance [1]. - The company has signed a strategic cooperation framework agreement with L Catterton Asia Advisors, aiming for global market expansion, acquisitions, strategic investments, capital structure optimization, and talent introduction. L Catterton will leverage its global investment network to assist the company in expanding high-end retail channels overseas and will jointly establish a private equity fund focused on the global high-end beauty sector [1]. Group 2 - Based on the company's strong sales performance in both online and offline channels, it is projected that the net profit attributable to the parent company will reach 1.21 billion, 1.58 billion, and 2.03 billion yuan for the years 2025, 2026, and 2027, representing year-on-year growth of 38%, 30%, and 28% respectively [2].

Core Viewpoint - South Korea aims to achieve annual exports exceeding $700 billion for the second consecutive year by 2026, despite global trade uncertainties [1][2]. Group 1: Export Performance - In 2025, South Korea's exports are projected to surpass $700 billion for the first time, reversing earlier pessimistic forecasts [1][2]. - Last year, South Korea achieved a record export value of $709.7 billion, driven by growth in key sectors such as semiconductors, automobiles, and shipbuilding, as well as small and medium-sized industries like agriculture, water products, and cosmetics [1][2]. Group 2: Government Initiatives - The Minister of Trade emphasized that the recovery of market trust in South Korea and the conclusion of the Korea-U.S. trade agreement contributed to the positive export outlook [1][2]. - The Ministry of Trade plans to diversify export projects and destinations to counteract trade protectionism from major economies, including stronger steel safeguard measures from the European Union, while also upgrading infrastructure and providing financial support to exporting companies [1][2].

Group 1 - In the fourth quarter of last year, notable fund managers such as Ge Lan and Tang Xiaobin reduced their holdings in Kelun Pharmaceutical, while Zhao Bei increased her stake [2][3] - Ge Lan's fund, the China Europe Medical Health Mixed Fund, held 38.1954 million shares of Kelun Pharmaceutical as of December 31, 2025, having reduced its holdings by 1.867 million shares compared to the end of the third quarter [4] - Tang Xiaobin's fund, the GF Multi-Factor Mixed Fund, exited the top ten shareholders of Kelun Pharmaceutical by the end of 2025, having reduced its holdings from 24.2335 million shares to an estimated 1.394 million shares [6] Group 2 - Zhao Bei's fund, the ICBC Credit Suisse Frontier Medical Equity Fund, increased its holdings in Kelun Pharmaceutical to 22 million shares by December 31, 2025, up by 2 million shares from the end of the third quarter [6] - The National Social Security Fund's 416 portfolio became the tenth largest shareholder of Kelun Pharmaceutical with 13.9445 million shares by the end of 2025 [6] Group 3 - Liu Yanchun and Hu Xinwei reduced their holdings in Proya Cosmetics, with Liu's fund holding 2.6 million shares as of December 30, 2025, down from 3.332 million shares at the end of the third quarter [8] - Hu Xinwei's fund exited the top ten shareholders of Proya Cosmetics by the end of 2025 [8] Group 4 - Zhou Yun's fund, the Dongfanghong New Energy Mixed Fund, and the National Social Security Fund's 404 portfolio entered the top ten shareholders of Jiazhe New Energy by the end of 2025 [10] - The National Social Security Fund's 114 portfolio increased its holdings in Nanshan Aluminum by 4.3432 million shares in the fourth quarter of 2025, with five ETF products included in the top ten shareholders of Nanshan Aluminum by the end of 2025 [10] Group 5 - A surge in institutional research activities has been noted, with over 10,000 research sessions conducted in the past month, focusing on sectors such as semiconductors, general equipment, automotive, and artificial intelligence [12] - Fund managers from various firms, including Chang'an Fund and Nord Fund, have actively participated in company research activities, indicating a strong interest in the market outlook for 2026 [13]

Group 1 - The core point of the article is that Mao Geping Cosmetics Co., Ltd. has announced a share reduction plan by its major shareholders, which includes a total reduction of up to 17.2 million H-shares, accounting for 3.51% of the company's total issued shares [2] - The shareholders plan to reduce their holdings mainly through block trading within six months due to personal financial needs, with proceeds intended for investments in the beauty industry and personal living improvements [2] - Mao Geping was listed on the Hong Kong Stock Exchange in December 2024, with an initial offering price of HKD 29.8, raising a total of HKD 2.337 billion, and a net fundraising amount of HKD 2.187 billion after deducting listing expenses [2] Group 2 - Mao Geping, the founder and current chairman of the company, has a background in the performing arts and established the company in 1998, while his wife, Wang Liqun, also plays a significant role in the company as vice chairman [3] - As of the last closing price, Mao Geping's stock was valued at HKD 87.95, giving the company a market capitalization of HKD 43.1 billion, allowing the family to potentially cash out HKD 1.5 billion [3]

Core Viewpoint - The cosmetics industry is still facing cyclical challenges, prompting leading companies like Estée Lauder to implement significant operational changes to regain growth [1] Group 1: Company Strategies - Estée Lauder has announced its largest operational transformation in history, termed "Reinventing Beauty" strategy, to navigate through industry difficulties [1] - Some mid-tier cosmetics companies are increasing R&D investments to differentiate their products, while others are opting for share reductions by management [1] Group 2: Shareholder Actions - On January 6, 2024, the Hong Kong-listed company Mao Geping announced plans for major share reductions by its controlling shareholders, amounting to a maximum of 17.2 million shares, or 3.51% of total shares [1] - The total cash raised from this share reduction could exceed 1.4 billion HKD, which will be used for investments in the beauty industry and personal expenses [1] Group 3: Market Performance - Mao Geping's stock price has seen significant appreciation, reaching a peak of over 130 HKD, four times its initial offering price of 29.8 HKD, and currently standing at 87.95 HKD [2] - The average daily trading volume for Mao Geping has been below 300 million HKD, indicating liquidity issues for a company valued over 40 billion HKD [3] Group 4: Financial Performance - For the first half of 2025, Mao Geping reported revenue of 2.588 billion CNY, a year-on-year increase of 31.28%, and a net profit of 670 million CNY, up 36.11% [3] - The company's gross margin stands at 84.2%, which is relatively high within the industry, but there are signs of slowing growth [3] - Sales and distribution expenses increased by 24.8% to 1.169 billion CNY, accounting for 45.2% of total revenue, with marketing expenses exceeding 540 million CNY [4] Group 5: Analyst Insights - Citibank noted that the share reduction by Mao Geping's controlling shareholders could exert short-term pressure on the stock price, but maintains a "Buy" rating with a target price of 82 HKD, predicting a 28% growth in earnings per share for 2025 [4][5] - The dynamic price-to-earnings ratio for Mao Geping is currently at 37.6 times, indicating a high valuation that may need to be addressed if growth does not continue [5][6]

Group 1 - Notable fund managers have disclosed their latest stock adjustments as the new year begins, with several companies announcing related updates [1] - Fund managers Ge Lan and Tang Xiaobin reduced their holdings in Kelun Pharmaceutical (002422), while Zhao Bei increased her stake [1][2] - Liu Yanchun and Hu Xinwei reduced their holdings in Proya (603605), while Zhou Yun entered the top ten shareholders of Jiazhe New Energy (601619) [1][6] Group 2 - As of December 31, 2025, Ge Lan's fund held 38.1954 million shares of Kelun Pharmaceutical, having reduced by 1.867 million shares compared to the previous quarter [2] - Tang Xiaobin's fund exited the top ten shareholders of Kelun Pharmaceutical by the end of 2025, having reduced holdings from 24.2335 million shares to 13.94 million shares [4] - Zhao Bei's fund increased its holdings in Kelun Pharmaceutical to 22 million shares, up by 2 million shares from the previous quarter [4] Group 3 - Liu Yanchun's fund held 2.6 million shares of Proya as of December 30, 2025, down from 3.332 million shares, indicating a reduction of over 700,000 shares [7] - Hu Xinwei's fund is no longer among the top ten shareholders of Proya [8] - Zhou Yun's fund and the National Social Security Fund 404 combination entered the top ten shareholders of Jiazhe New Energy in the fourth quarter of 2025 [9] Group 4 - The National Social Security Fund 114 combination increased its holdings in Nanshan Aluminum (600219) by 4.3432 million shares in the fourth quarter of 2025 [9] - By the end of 2025, five ETF products were included among the top ten shareholders of Nanshan Aluminum, indicating the growing influence of index funds [9] Group 5 - A significant increase in institutional research activities has been noted, with over 10,000 research sessions conducted in the past month, focusing on sectors such as semiconductors, general equipment, automotive, and artificial intelligence [10] - Fund managers are optimistic about the performance of non-financial listed companies in A-shares for 2025 and 2026, anticipating a stable recovery [10]

Core Viewpoint - The article discusses the recent stock adjustments made by several well-known fund managers, highlighting their changes in holdings in various companies, particularly focusing on Kelong Pharmaceutical and Proya Cosmetics [2]. Group 1: Kelong Pharmaceutical - Fund managers Ge Lan and Tang Xiaobin reduced their holdings in Kelong Pharmaceutical, while Zhao Bei increased her stake [3]. - As of December 31, 2025, Ge Lan's fund held 38.1954 million shares of Kelong Pharmaceutical, a decrease of 1.867 million shares compared to the end of the third quarter [4]. - Tang Xiaobin's fund, Guangfa Multi-Factor Mixed Fund, exited the top ten shareholders of Kelong Pharmaceutical by the end of 2025, having reduced its holdings from 24.2335 million shares to at least 10.2935 million shares [6]. - In contrast, Zhao Bei's fund held 22 million shares of Kelong Pharmaceutical as of December 31, 2025, an increase of 2 million shares from the previous quarter [6]. - The National Social Security Fund's 416 portfolio became the tenth largest shareholder of Kelong Pharmaceutical with 13.9445 million shares by the end of 2025 [7]. Group 2: Proya Cosmetics - Liu Yanchun and Hu Xinwei reduced their holdings in Proya Cosmetics, with Liu's fund holding 2.6 million shares as of December 30, 2025, down from 3.332 million shares [9]. - Hu Xinwei's fund is no longer among the top ten shareholders of Proya Cosmetics [10]. Group 3: Other Companies - Zhou Yun's fund and the National Social Security Fund's 404 portfolio entered the top ten shareholders of Jiazhe New Energy by the end of 2025 [11]. - The National Social Security Fund's 114 portfolio increased its holdings in Nanshan Aluminum by 4.3432 million shares in the fourth quarter of 2025, with five ETF products now included among the top ten shareholders [11]. Group 4: Market Trends - As of early 2026, A-shares stabilized above 4000 points, with over 10,000 institutional research activities focused on sectors like semiconductors and artificial intelligence [13]. - Fund managers express optimism for A-share performance in 2026, anticipating a recovery in earnings growth for non-financial listed companies [13].

Core Viewpoint - The announcement of share reduction by the controlling shareholders of Mao Geping Cosmetics Co., Ltd. indicates a strategic move to meet personal financial needs while expressing confidence in the company's future development [2][3]. Group 1: Share Reduction Announcement - On January 6, Mao Geping announced that six controlling shareholders, including founders Mao Geping and Wang Liqun, plan to reduce their holdings by up to 17.2 million H-shares, representing 3.51% of the total issued shares within six months [2]. - The share price saw an increase of 5.3% on January 7, with a trading range between 81.75 HKD and 88.90 HKD, allowing the shareholders to potentially cash out at least 1.4 billion HKD [2]. - The shareholders' stated purpose for the reduction includes personal financial needs and investments in the beauty industry, while emphasizing their ongoing commitment to product development and management [2]. Group 2: Market Context and Performance - Mao Geping was listed on the Hong Kong Stock Exchange in October 2024, initially priced at 29.8 HKD, with the opening price reaching 47.65 HKD, nearly doubling since then [3]. - The timing of the share reduction coincides with the first window period after the lifting of the lock-up period, which typically lasts for 12 months for controlling shareholders and executives [3].

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The report highlights that the reduction in shareholding by major shareholders has been completed, which is expected to contribute to the creation of a high-end luxury beauty ecosystem [5] - The company has signed a strategic cooperation framework agreement with L Catterton Asia Advisors to assist in global market expansion, acquisitions, and strategic investments [8] - The company's strong sales performance in both online and offline channels supports the positive outlook for its future profitability [8] Financial Performance and Forecast - Revenue projections for the company are as follows: - 2023: 2,885.96 million RMB - 2024: 3,884.69 million RMB (growth of 34.61%) - 2025: 5,153.06 million RMB (growth of 32.65%) - 2026: 6,608.46 million RMB (growth of 28.24%) - 2027: 8,340.36 million RMB (growth of 26.21%) [7] - Net profit forecasts are: - 2023: 661.9 million RMB - 2024: 880.6 million RMB (growth of 33.0%) - 2025: 1,212.7 million RMB (growth of 37.7%) - 2026: 1,580.4 million RMB (growth of 30.3%) - 2027: 2,030.8 million RMB (growth of 28.5%) [7] - Earnings per share (EPS) estimates are: - 2023: 3.31 RMB - 2024: 2.18 RMB - 2025: 2.47 RMB - 2026: 3.22 RMB - 2027: 4.14 RMB [7] Strategic Developments - The company plans to utilize the proceeds from the share reduction for investments in the beauty-related industry and personal improvements [8] - The collaboration with L Catterton aims to leverage their global investment network to enhance the company's brand presence in high-end retail channels [8]

Core Viewpoint - The article discusses the share reduction announcement by Mao Geping Cosmetics Co., Ltd., highlighting the planned sale of up to 17.2 million H-shares by major shareholders, including the founders, for personal financial needs while expressing confidence in the company's future [3][4]. Group 1 - Mao Geping announced a share reduction plan involving six major shareholders, including the founders, intending to sell up to 17.2 million H-shares, which is 3.51% of the total issued shares [3]. - Following the announcement, the company's stock price rose by 5.3%, with a trading range between 81.75 HKD and 88.90 HKD, potentially allowing the shareholders to cash out at least 1.4 billion HKD [3]. - The purpose of the share reduction is attributed to personal financial needs, with proceeds intended for investments in the beauty industry and personal lifestyle improvements [3]. Group 2 - Mao Geping was listed on the Hong Kong Stock Exchange in October 2024, initially priced at 29.8 HKD, with the opening price reaching 47.65 HKD, indicating nearly a twofold increase in stock price since then [4]. - The timing of the share reduction coincides with the first window of opportunity following the expiration of the 12-month lock-up period for major shareholders and executives [5].